查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1424051

抗寄生虫药市场、份额、规模、趋势、产业分析报告：按类型、给药途径、分销管道、地区、细分市场预测，2024-2032

Antiparasitic Drugs Market Share, Size, Trends, Industry Analysis Report, By Type (Antiprotozoals, Anthelmintics, Others); By Route of Administration; By Distribution Channel; By Region; Segment Forecast, 2024- 2032
出版日期: | 出版商: Polaris Market Research | 英文 118 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，到 2032 年，全球抗寄生虫药物市场预计将达到 382 亿美元。 该研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

发展中地区的新兴市场为抗寄生虫药物市场提供了巨大机会。 医疗基础设施的改善和意识的提高正在推动对寄生虫感染有效治疗的需求。 由于这些地区的感染率较高，製药公司正在推出方便且负担得起的解决方案，并建立策略联盟以进入和扩张市场。

标靶治疗是抗寄生虫药物市场的一个重要机会，它提供精确和个人化的治疗，以提高疗效并最大限度地减少副作用。 利用分子理解的进步，这些治疗针对特定的寄生虫，并提供创新的解决方案来改善患者的治疗结果。 投资此类针对性方法研发的製药公司可望引领市场。 这项策略性措施扩大了治疗选择，同时解决了抗药性的挑战，并符合抗寄生虫药物开发中个人化医疗的发展。

临床试验在塑造抗寄生虫药物市场方面发挥着至关重要的作用。 除了验证安全性和有效性之外，製药公司还透过参与严格的临床试验来确立自己的创新者地位。 成功的临床试验不仅能获得监管部门的批准，还能建立可信度并获得竞争优势。 这种参与增强了医疗保健专业人员之间的信任，并有助于市场成长。 此外，此类临床试验将扩大可用治疗方案的范围，满足对抗寄生虫感染不断变化的需求，并确保市场的持续扩张。

简化的监管途径、加速的审批和支持性框架为製药创新创造了有利的环境。 这使得公司能够将新型抗寄生虫药物快速推向市场并满足重要的医疗保健需求。 监管机构和行业利益相关者之间的合作将实现高效的流程并促进及时的市场准入。 创新解决方案的鼓励加上加速的监管框架正在推动抗寄生虫药物市场的持续成长。

抗寄生虫药物市场报告重点

2023年，由于蠕虫感染的流行、全球健康活动和意识的提高，驱虫药行业占据了较大的市场份额。

2023年，由于快速、直接的反应以及在医院的广泛使用，注射剂领域占据了很大的市场份额。

2023 年，医院药局业务由于医疗机构内的患者可以轻鬆取得而占据了很大的收入份额。

2023年，由于寄生虫感染的流行、监管环境和研发，北美地区主导了全球市场。

该市场由具有全球影响力的市场参与者主导，例如拜耳公司、Cipla Limited、F. Hoffmann-La Roche Ltd.、葛兰素史克、Ipca Laboratories Ltd.、Merck &Co、Viatris 和 Novartis，竞争很激烈。

目录

第1章简介

第 2 章执行摘要

第3章研究方法

第4章全球抗寄生虫药物市场洞察

  • 抗寄生虫药市场－通路概况
  • 抗寄生虫药物市场动态
    • 推动者和机会
      • 全球健康措施预计将刺激产品需求
      • 寄生虫感染的流行预计将推动抗寄生虫药物市场的成长
    • 抑制因素和挑战
      • 监理挑战可能会阻碍市场成长
  • PESTEL 分析
  • 抗寄生虫药市场通路趋势
  • 价值链分析
  • COVID-19 感染的影响分析

第五章全球抗寄生虫药物市场，依类型

  • 主要发现
  • 简介
  • 抗原虫药
  • 驱虫药
  • 其他

第 6 章全球抗寄生虫药物市场（依给药途径）

  • 主要发现
  • 简介
  • 本地
  • 口头
  • 注射

第 7 章全球抗寄生虫药物市场（按分销管道）

  • 主要发现
  • 简介
  • 零售药局
  • 医院药房
  • 其他

第 8 章全球抗寄生虫药物市场（按地区）

  • 主要发现
  • 简介
    • 抗寄生虫药物市场评估，地区，2019-2032
  • 抗寄生药物市场 - 北美
    • 北美：2019-2032 年抗寄生虫药物市场（按类型）
    • 北美：抗寄生虫药物市场，依通路划分，2019-2032 年
    • 北美：2019-2032 年抗寄生虫药物市场（依给药途径）
    • 抗寄生药物市场 - 美国
    • 抗寄生药物市场 - 加拿大
  • 抗寄生药物市场 - 欧洲
    • 欧洲：2019-2032 年抗寄生虫药物市场（按类型）
    • 欧洲：抗寄生虫药物市场，依通路划分，2019-2032 年
    • 欧洲：2019-2032 年抗寄生虫药物市场（依给药途径）
    • 抗寄生药物市场 - 英国
    • 抗寄生药物市场 - 法国
    • 抗寄生药物市场 - 德国
    • 抗寄生药物市场 - 义大利
    • 抗寄生药物市场 - 西班牙
    • 抗寄生药物市场 - 荷兰
    • 抗寄生药物市场 - 俄罗斯
  • 抗寄生虫药物市场 - 亚太地区
    • 亚太地区：2019-2032 年抗寄生虫药物市场（按类型）
    • 亚太地区：抗寄生虫药物市场，依通路划分，2019-2032 年
    • 亚太地区：抗寄生虫药物市场（依给药途径），2019-2032 年
    • 抗寄生药物市场 - 中国
    • 抗寄生药物市场 - 印度
    • 抗寄生药物市场 - 马来西亚
    • 抗寄生药物市场 - 日本
    • 抗寄生药物市场 - 印度尼西亚
    • 抗寄生药物市场 - 韩国
  • 抗寄生虫药物市场 - 中东和非洲
    • 中东和非洲：2019-2032 年抗寄生虫药物市场（按类型）
    • 中东和非洲：抗寄生虫药物市场，按分销管道划分，2019-2032 年
    • 中东和非洲：2019-2032 年抗寄生虫药物市场（依给药途径）
    • 抗寄生虫药物市场 - 沙乌地阿拉伯
    • 抗寄生虫药物市场 - 阿拉伯联合大公国
    • 抗寄生药物市场 - 以色列
    • 抗寄生药物市场 - 南非
  • 抗寄生药物市场 - 拉丁美洲
    • 拉丁美洲：2019-2032 年抗寄生虫药物市场（按类型）
    • 拉丁美洲：抗寄生虫药物市场，依通路划分，2019-2032 年
    • 拉丁美洲：2019-2032 年抗寄生虫药物市场（依给药途径）
    • 抗寄生药物市场 - 墨西哥
    • 抗寄生药物市场 - 巴西
    • 抗寄生药物市场 - 阿根廷

第9章竞争态势

  • 扩张与收购分析
    • 放大
    • 收购
  • 伙伴关係/协作/协议/揭露

第10章公司简介

  • AstraZeneca
  • Bayer AG
  • Cipla Limited
  • Dr. Reddy's Laboratories
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline
  • Ipca Laboratories Ltd
  • Lupin Pharmaceuticals
  • Merck & Co.
  • Novartis
  • Pfizer
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
  • Viatris
  • Zydus Group
Product Code: PM4409

The global Antiparasitic Drugs market size is expected to reach USD 38.20 billion by 2032, according to a new study by Polaris Market Research. The report "Antiparasitic Drugs Market Share, Size, Trends, Industry Analysis Report, By Type (Antiprotozoals, Anthelmintics, Others); By Route of Administration; By Distribution Channel; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Emerging markets in developing regions offer prime opportunities for the Antiparasitic Drugs Market. Improved healthcare infrastructure and heightened awareness drive demand for effective treatments against parasitic infections. With higher infection rates in these regions, pharmaceutical companies introduce accessible and affordable solutions, establishing strategic collaborations for market entry and expansion.

Targeted therapies present a pivotal opportunity in the antiparasitic drugs market, offering precise, personalized treatment for enhanced efficacy and minimized side effects. Leveraging advancements in molecular understanding, these therapies focus on specific parasites, providing innovative solutions with improved patient outcomes. Pharmaceutical companies investing in research and development of such targeted approaches position themselves for market leadership. This strategic move addresses the challenges of drug resistance while expanding treatment options, aligning with the evolving landscape of personalized medicine in antiparasitic drug development.

Clinical trials play a pivotal role in shaping the antiparasitic drugs market. Beyond validating safety and efficacy, participation in rigorous trials positions pharmaceutical companies as innovators. Successful trials not only secure regulatory approvals but also establish credibility, gaining a competitive edge. This engagement fosters confidence among healthcare professionals, contributing to market growth. Furthermore, these trials broaden the spectrum of available treatment options, meeting evolving needs in the fight against parasitic infections and ensuring sustained market expansion.

Streamlined regulatory pathways, expedited approvals, and supportive frameworks create a conducive environment for pharmaceutical innovation. This backing allows companies to swiftly bring novel antiparasitic drugs to market, addressing critical healthcare needs. Collaborative efforts between regulatory bodies and industry players enable efficient processes, fostering timely market entry. The encouragement of innovative solutions, coupled with responsive regulatory frameworks, positions the antiparasitic drugs Market for sustained growth.

Antiparasitic Drugs Market Report Highlights

In 2023, the Anthelmintics segment accounted for significant market share owing to prevalence of helminthic infections, global health initiatives, and increased awareness.

In 2023, the injectable segment accounted for significant market share owing to rapid and direct response, and wide use in hospitals.

In 2023, the hospital pharmacy segment held significant revenue share owing to easy access for patients within healthcare institutions.

In 2023, North America region dominated the global market due to prevalence of parasitic infections, regulatory environment, and research and development.

The market is highly competitive owing to the existence of market players with a global presence, including Bayer AG, Cipla Limited, F. Hoffmann-La Roche Ltd., GlaxoSmithKline, Ipca Laboratories Ltd, Merck & Co., Viatris, and Novartis among others.

Polaris Market Research has segmented the Antiparasitic Drugs market report based on type, route of administration, distribution channel, and region:

Antiparasitic Drugs, Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Antiprotozoals
  • Anthelmintics
  • Others

Antiparasitic Drugs, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)

  • Topical
  • Oral
  • Injectable

Antiparasitic Drugs, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)

  • Retail Pharmacy
  • Hospital Pharmacy
  • Others

Antiparasitic Drugs, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • France
  • Germany
  • UK
  • Italy
  • Netherlands
  • Spain
  • Russia
  • Asia Pacific
  • Japan
  • China
  • India
  • Malaysia
  • Indonesia
  • South Korea
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Antiparasitic Drugs Market Insights

  • 4.1. Antiparasitic Drugs Market - Distribution Channel Snapshot
  • 4.2. Antiparasitic Drugs Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Global health initiatives are projected to spur the product demand
      • 4.2.1.2. Prevalence of parasitic infections is expected to drive antiparasitic drugs market growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Regulatory challenges are likely to impede the market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Antiparasitic Drugs Market Distribution Channel Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Antiparasitic Drugs Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • 5.3. Antiprotozoals
    • 5.3.1. Global Antiparasitic Drugs Market, by Antiprotozoals, by Region, 2019-2032 (USD Billion)
  • 5.4. Anthelmintics
    • 5.4.1. Global Antiparasitic Drugs Market, by Anthelmintics, by Region, 2019-2032 (USD Billion)
  • 5.5. Others
    • 5.5.1. Global Antiparasitic Drugs Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Antiparasitic Drugs Market, by Route of Administration

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • 6.3. Topical
    • 6.3.1. Global Antiparasitic Drugs Market, by Topical, by Region, 2019-2032 (USD Billion)
  • 6.4. Oral
    • 6.4.1. Global Antiparasitic Drugs Market, by Oral, by Region, 2019-2032 (USD Billion)
  • 6.5. Injectable
    • 6.5.1. Global Antiparasitic Drugs Market, by Injectable, by Region, 2019-2032 (USD Billion)

7. Global Antiparasitic Drugs Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 7.3. Retail Pharmacy
    • 7.3.1. Global Antiparasitic Drugs Market, by Retail Pharmacy, By Region, 2019-2032 (USD Billion)
  • 7.4. Hospital Pharmacy
    • 7.4.1. Global Antiparasitic Drugs Market, by Hospital Pharmacy, By Region, 2019-2032 (USD Billion)
  • 7.5. Others
    • 7.5.1. Global Antiparasitic Drugs Market, by Others, By Region, 2019-2032 (USD Billion)

8. Global Antiparasitic Drugs Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Antiparasitic Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Antiparasitic Drugs Market - North America
    • 8.3.1. North America: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
    • 8.3.2. North America: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.3.3. North America: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.3.4. Antiparasitic Drugs Market - U.S.
      • 8.3.4.1. U.S.: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.3.5. Antiparasitic Drugs Market - Canada
      • 8.3.5.1. Canada: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • 8.4. Antiparasitic Drugs Market - Europe
    • 8.4.1. Europe: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.4.4. Antiparasitic Drugs Market - UK
      • 8.4.4.1. UK: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.4.5. Antiparasitic Drugs Market - France
      • 8.4.5.1. France: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.4.6. Antiparasitic Drugs Market - Germany
      • 8.4.6.1. Germany: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.4.7. Antiparasitic Drugs Market - Italy
      • 8.4.7.1. Italy: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.4.8. Antiparasitic Drugs Market - Spain
      • 8.4.8.1. Spain: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.4.9. Antiparasitic Drugs Market - Netherlands
      • 8.4.9.1. Netherlands: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.4.10. Antiparasitic Drugs Market - Russia
      • 8.4.10.1. Russia: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • 8.5. Antiparasitic Drugs Market - Asia Pacific
    • 8.5.1. Asia Pacific: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.5.4. Antiparasitic Drugs Market - China
      • 8.5.4.1. China: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.5.5. Antiparasitic Drugs Market - India
      • 8.5.5.1. India: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.5.6. Antiparasitic Drugs Market - Malaysia
      • 8.5.6.1. Malaysia: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.5.7. Antiparasitic Drugs Market - Japan
      • 8.5.7.1. Japan: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.5.8. Antiparasitic Drugs Market - Indonesia
      • 8.5.8.1. Indonesia: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.5.9. Antiparasitic Drugs Market - South Korea
      • 8.5.9.1. South Korea: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • 8.6. Antiparasitic Drugs Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.6.4. Antiparasitic Drugs Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.6.5. Antiparasitic Drugs Market - UAE
      • 8.6.5.1. UAE: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.6.6. Antiparasitic Drugs Market - Israel
      • 8.6.6.1. Israel: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.6.7. Antiparasitic Drugs Market - South Africa
      • 8.6.7.1. South Africa: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • 8.7. Antiparasitic Drugs Market - Latin America
    • 8.7.1. Latin America: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.7.4. Antiparasitic Drugs Market - Mexico
      • 8.7.4.1. Mexico: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.7.5. Antiparasitic Drugs Market - Brazil
      • 8.7.5.1. Brazil: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.7.6. Antiparasitic Drugs Market - Argentina
      • 8.7.6.1. Argentina: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. AstraZeneca
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Bayer AG
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Cipla Limited
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Dr. Reddy's Laboratories
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. F. Hoffmann-La Roche Ltd
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. GlaxoSmithKline
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Ipca Laboratories Ltd
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Lupin Pharmaceuticals
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Merck & Co.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Novartis
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Pfizer
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Sanofi
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Sun Pharmaceutical Industries Ltd.
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Viatris
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Zydus Group
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development

List of Tables

  • Table 1 Global Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 2 Global Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 3 Global Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 4 Antiparasitic Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 6 North America: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 7 North America: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 8 U.S.: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 9 U.S.: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 10 U.S.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 11 Canada: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 12 Canada: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 13 Canada: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 14 Europe: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 15 Europe: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 16 Europe: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 17 UK: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 18 UK: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 19 UK: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 20 France: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 21 France: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 22 France: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 23 Germany: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 24 Germany: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 25 Germany: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 26 Italy: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 27 Italy: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 28 Italy: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 29 Spain: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 30 Spain: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 31 Spain: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 35 Russia: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 36 Russia: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 37 Russia: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 41 China: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 42 China: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 43 China: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 44 India: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 45 India: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 46 India: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 50 Japan: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 51 Japan: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 52 Japan: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 56 South Korea: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 57 South Korea: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 58 South Korea: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 65 UAE: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 66 UAE: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 67 UAE: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 68 Israel: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 69 Israel: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 70 Israel: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 71 South Africa: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 72 South Africa: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 73 South Africa: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 74 Latin America: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 75 Latin America: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 76 Latin America: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 77 Mexico: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 78 Mexico: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 79 Mexico: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 80 Brazil: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 81 Brazil: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 82 Brazil: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 83 Argentina: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 84 Argentina: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 85 Argentina: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Antiparasitic Drugs Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Route of Administration
  • Figure 7. Global Antiparasitic Drugs Market, by Route of Administration, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Type
  • Figure 9. Global Antiparasitic Drugs Market, by Type, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Distribution Channel
  • Figure 11. Global Antiparasitic Drugs Market, by Distribution Channel, 2022 & 2032 (USD Billion)
  • Figure 12. Antiparasitic Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Antiparasitic Drugs Market